Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
211M
-
Number of holders
-
125
-
Total 13F shares, excl. options
-
75.9M
-
Shares change
-
+1.26M
-
Total reported value, excl. options
-
$2.37B
-
Value change
-
+$39.1M
-
Put/Call ratio
-
0.85
-
Number of buys
-
70
-
Number of sells
-
-80
-
Price
-
$31.18
Significant Holders of INSMED Inc - Common Stock, par value $0.01 per share (INSM) as of Q4 2017
185 filings reported holding INSM - INSMED Inc - Common Stock, par value $0.01 per share as of Q4 2017.
INSMED Inc - Common Stock, par value $0.01 per share (INSM) has 125 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 75.9M shares
of 211M outstanding shares and own 35.97% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (13M shares), FMR LLC (11.5M shares), BlackRock Inc. (7.83M shares), Palo Alto Investors, LLC (6.4M shares), Vanguard Group Inc (6.31M shares), JANUS HENDERSON GROUP PLC (5.96M shares), STATE STREET CORP (2.91M shares), Redmile Group, LLC (2.25M shares), ORBIMED ADVISORS LLC (1.5M shares), and NORTHERN TRUST CORP (954K shares).
This table shows the top 125 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.